-
EXCLUSIVE: Expect Amarin FAQ Shortly
Monday, November 9, 2015 - 12:14pm | 166Read More...Traders should expect an FAQ posted to Amarin Corporation plc (ADR) (NASDAQ: AMRN)'s website within an hour, a company spokesperson commented to Benzinga. Editor's note: The FAQ has been updated and can be viewed here. Amarin's release is expected to add insight to an earlier...
-
Amarin's Vascepa: Too Limited A Market Or FDA Blunder?
Wednesday, December 18, 2013 - 3:11pm | 1018Read More...Is Amarin's (NASDAQ: AMRN) Vascepa the victim of its own ineptitude, or the target of an effort by Big Pharma to keep it off the market? Those questions and others have been lobbed around lately by a variety of industry observers and investors, regarding Amarin's sole product, Vascepa – a...
